Abstract
<h3>In Reply.</h3> —The effectiveness of aminocaproic acid in preventing secondary hemorrhage in traumatic hyphemas has been demonstrated both in a prospective, randomized, double-masked, controlled clinical study<sup>1</sup>and in basic pharmacologic studies.<sup>2</sup>Three additional clinical studies and one animal model have confirmed these results.<sup>3-6</sup>The secondary hemorrhage rate in these studies with placebo was very similar (28% to 33%). The rate of secondary hemorrhage in those patients treated with aminocaproic acid was 0% to 4%. These scientific studies by different authors at different institutions provide ample scientific evidence to support the use of aminocaproic acid in the treatment of traumatic hyphema. Dr Romano has suggested the use of systemic steroids in traumatic hyphema treatment to circumvent the problems with aminocaproic acid. Unfortunately, there is little basic pharmacologic research to support his claim. Low concentrations of glucocorticoids have been demonstrated to retard the ability of neutrophils to promote conversion
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
